ATE129899T1 - Verwendung von il-7 bei arzneimitteln zur steigerung der plättchenherstellung. - Google Patents

Verwendung von il-7 bei arzneimitteln zur steigerung der plättchenherstellung.

Info

Publication number
ATE129899T1
ATE129899T1 AT90904051T AT90904051T ATE129899T1 AT E129899 T1 ATE129899 T1 AT E129899T1 AT 90904051 T AT90904051 T AT 90904051T AT 90904051 T AT90904051 T AT 90904051T AT E129899 T1 ATE129899 T1 AT E129899T1
Authority
AT
Austria
Prior art keywords
plateet
drugs
manufacturing
increase
interleukin
Prior art date
Application number
AT90904051T
Other languages
English (en)
Inventor
Douglas E Williams
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Application granted granted Critical
Publication of ATE129899T1 publication Critical patent/ATE129899T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5418—IL-7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90904051T 1989-02-17 1990-02-06 Verwendung von il-7 bei arzneimitteln zur steigerung der plättchenherstellung. ATE129899T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/312,546 US5032396A (en) 1989-02-17 1989-02-17 IL-7 to stimulate platelet production

Publications (1)

Publication Number Publication Date
ATE129899T1 true ATE129899T1 (de) 1995-11-15

Family

ID=23211955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90904051T ATE129899T1 (de) 1989-02-17 1990-02-06 Verwendung von il-7 bei arzneimitteln zur steigerung der plättchenherstellung.

Country Status (10)

Country Link
US (1) US5032396A (de)
EP (1) EP0412149B1 (de)
JP (1) JP2840443B2 (de)
AT (1) ATE129899T1 (de)
AU (1) AU628943B2 (de)
CA (1) CA2026783C (de)
DE (1) DE69023416T2 (de)
DK (1) DK0412149T3 (de)
ES (1) ES2081366T3 (de)
WO (1) WO1990009194A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714585A (en) * 1987-10-26 1998-02-03 Sterling Winthrop, Inc. Antibodies that are immunoreactive with interleukin-7
US5260417A (en) * 1989-04-03 1993-11-09 Genetics Institute, Inc. Megakaryocyte growth promoting activity protein
US5229115A (en) * 1990-07-26 1993-07-20 Immunex Corporation Adoptive immunotherapy with interleukin-7
DE69129697T3 (de) * 1990-08-29 2004-01-29 Inst Genetics Llc Aus mehreren domänen bestehende hämatopoese-stimulatoren
US5474769A (en) * 1991-03-08 1995-12-12 Sterling Winthrop Inc. Treatment of microbial infection by monocyte stimulation with interleukin-7
US5250732A (en) * 1991-07-18 1993-10-05 Genentech, Inc. Ketamine analogues for treatment of thrombocytopenia
AU4190893A (en) * 1992-07-17 1994-01-20 Suntory Limited Megakaryocyte differentiation factor
ATE291624T1 (de) * 1992-12-16 2005-04-15 Hexima Ltd Ein proteinase inhibitor, vorläufer davon und genetische sequenzen dafür kodierend
US5498599A (en) * 1994-01-21 1996-03-12 Amgen Inc. Methods for stimulating platelet production
US5547931A (en) * 1994-02-23 1996-08-20 Immtech International Inc. Methods of stimulatory thrombocytopoiesis using modified C-reactive protein
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
US6242417B1 (en) 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
GEP20002180B (en) * 1994-03-31 2000-07-25 Amgen Inc Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
US5795569A (en) * 1994-03-31 1998-08-18 Amgen Inc. Mono-pegylated proteins that stimulate megakaryocyte growth and differentiation
RU2158603C2 (ru) * 1994-05-31 2000-11-10 Амген Инк. Способы и препараты для стимулирования роста и дифференцировки мегакариоцитов
CA2206496A1 (en) * 1994-11-30 1996-06-06 Chugai Seiyaku Kabushiki Kaisha Thrombocytotic factor
EP0721780A3 (de) * 1994-12-16 1997-12-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Mittel zur Förderung von Plättchen und/oder Leucozytenherstellung
FR2745185B1 (fr) * 1996-02-28 1998-05-15 Sanofi Sa Utilisation de l'il-7 dans le traitement des maladies auto-immunes, en particulier le diabete mellitus insulinodependant
US6589759B1 (en) 1999-03-30 2003-07-08 Trustees Of Boston University Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
EP2295450B1 (de) 2000-09-29 2015-01-28 Merck Sharp & Dohme Corp. Pegyliertes interleukin 10
WO2002085300A2 (en) * 2001-04-23 2002-10-31 The Regents Of The University Of California Methods of using interleukin-7 to modulate physiological processes in mammalian pulmonary fibroblasts
ES2331420T3 (es) * 2003-09-10 2010-01-04 S-Cell Biosciences, Inc. Composiciones basadas en el factor inmuno-estimulante t-4 ("tisf") para el tratamiento de la carencia de globulos rojos, granulocitos y plaquetas.
EP2066336B1 (de) 2006-09-28 2012-09-19 Merck Sharp & Dohme Corp. Verwendung von pegyliertem il-10 zur krebsbehandlung
MX2015014438A (es) 2013-04-18 2016-05-18 Armo Biosciences Inc Metodos de uso de interleucina-10 para tratar enfermedades y trastornos.
EP3010527B1 (de) 2013-06-17 2018-08-08 Armo Biosciences, Inc. Verfahren zur beurteilung der proteinidentität und -stabilität
CN120242030A (zh) 2013-11-11 2025-07-04 阿尔莫生物科技股份有限公司 将白细胞介素-10用于治疗疾病和病症的方法
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
AU2015336101A1 (en) 2014-10-22 2017-04-20 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
US20160361415A1 (en) 2015-05-28 2016-12-15 Armo Biosciences, Inc. Methods of Using Interleukin-10 for Treating Diseases and Disorders
KR20180038553A (ko) 2015-08-25 2018-04-16 아르모 바이오사이언시스 인코포레이티드 질환 및 장애를 치료하기 위한 인터류킨-10을 사용하는 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894440A (en) * 1986-09-17 1990-01-16 Massachusetts Institute Of Technology Method of isolating megakaryocyte stimulatory factor
ZA887773B (en) * 1987-10-26 1989-07-26 Immunex Corp Interleukin-7

Also Published As

Publication number Publication date
ES2081366T3 (es) 1996-03-01
DK0412149T3 (da) 1995-12-11
WO1990009194A1 (en) 1990-08-23
JP2840443B2 (ja) 1998-12-24
JPH04501421A (ja) 1992-03-12
EP0412149B1 (de) 1995-11-08
AU5164590A (en) 1990-09-05
US5032396A (en) 1991-07-16
DE69023416T2 (de) 1996-06-27
AU628943B2 (en) 1992-09-24
DE69023416D1 (de) 1995-12-14
EP0412149A4 (en) 1992-12-09
CA2026783C (en) 1996-08-06
EP0412149A1 (de) 1991-02-13
CA2026783A1 (en) 1990-08-18

Similar Documents

Publication Publication Date Title
ATE129899T1 (de) Verwendung von il-7 bei arzneimitteln zur steigerung der plättchenherstellung.
DE3884372D1 (de) Die Verwendung von Maltitiol in Kaugummimassen zur Verbesserung der physikalischen Stabilität.
DE3780933D1 (de) Herstellung von aminoalanen.
DE3872495D1 (de) Herstellung von 3,3,3-trifluoropropen.
ATE112802T1 (de) Herstellung von funktionellen menschlichen urokinasepolypeptiden.
DE58904511D1 (de) Montageverfahren zur herstellung von led-zeilen.
IT8921893A0 (it) Procedimento per la produzione di impiallacciatura artificiale ad imitazione della radica, mediante bruciature.
DE3789316D1 (de) Herstellung von human-parathyroidhormon.
DE3785693D1 (de) Herstellung von keramischem material.
DE69023989D1 (de) Verwendung von Vitamin B6 zur Verminderung von hohem Serotoninspiegel.
ES541599A0 (es) Procedimiento para producir el factor viii-c humano
DE3876769D1 (de) Mikrobiologische herstellung von 9-alpha-hydroxy-17-keto-steroiden.
DE69213447D1 (de) Herstellung von n-acylimidazolen
DE3875281D1 (de) Herstellung von pseudoiononen.
DE3881996D1 (de) Lichtemittierende diode und herstellungsverfahren.
IT8921894A0 (it) Procedimento per la produzione di impiallacciatura di radica artificiale mediante fogli di legno rigati.
IT1213100B (it) La produzione di prodotti sessuali impiego di sostanze stimolanti per da mammiferi,adatti per la fecondazione naturale ed artificiale e sostanze relative
NO885200D0 (no) FremgangsmŸte for fremstilling av pro-legemidler.
IT8819237A0 (it) Procedimento per la produzione di bricchette di combustibile senza fumo trattate.
DE68917379D1 (de) Verfahren zur Herstellung von Proteinen, die ähnlich dem natürlich-menschlichen Apolipoprotein-E sind.
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.
DE3889371D1 (de) Verfahren zur Herstellung von supraleitenden Keramiken.
DE3869831D1 (de) Elektrolytische herstellung von chlordioxid.
IT8719363A0 (it) Procedimento per la produzione di calcourea.
DE69005566D1 (de) Herstellung von para-phenylendiaminen.

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time